GN Store Nord (OTCMKTS:GNNDY – Get Free Report) and Sensus Healthcare (NASDAQ:SRTS – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, institutional ownership, earnings and dividends.
Analyst Recommendations
This is a summary of current ratings and target prices for GN Store Nord and Sensus Healthcare, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| GN Store Nord | 0 | 3 | 2 | 0 | 2.40 |
| Sensus Healthcare | 1 | 1 | 4 | 0 | 2.50 |
Sensus Healthcare has a consensus price target of $5.83, suggesting a potential upside of 75.18%. Given Sensus Healthcare’s stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than GN Store Nord.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| GN Store Nord | $2.54 billion | 0.89 | $98.86 million | ($1.80) | -24.97 |
| Sensus Healthcare | $27.48 million | 1.99 | -$7.72 million | ($0.94) | -3.54 |
GN Store Nord has higher revenue and earnings than Sensus Healthcare. GN Store Nord is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares GN Store Nord and Sensus Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| GN Store Nord | -4.32% | -2.42% | -0.88% |
| Sensus Healthcare | -88.45% | -21.57% | -19.20% |
Institutional and Insider Ownership
25.3% of Sensus Healthcare shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Volatility and Risk
GN Store Nord has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500.
Summary
Sensus Healthcare beats GN Store Nord on 8 of the 14 factors compared between the two stocks.
About GN Store Nord
GN Store Nord A/S provides hearing, audio, video, and gaming solutions in Denmark, rest of Europe, North America, and internationally. The company operates through GN Hearing and GN Audio segments. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets, video cameras, and speakerphones for professional use and consumer products. It offers its products under the ReSound, Jabra, Beltone, Interton, Danavox, BlueParrott, FalCom, and SteelSeries brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.
About Sensus Healthcare
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Receive News & Ratings for GN Store Nord Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GN Store Nord and related companies with MarketBeat.com's FREE daily email newsletter.
